Tuomanen, Elaine I
- St. Jude Children's Research Hospital · Microbiology & Immunology (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,505
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$910K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,505
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Tuomanen, Elaine I as a PI. Multi-PI records show the full award amount for context.
- 5R01AI128756-07R01Contact PIBioactivities of pneumococcal cell wall in neuropathogenesisSt. Jude Children's Research Hospital · Microbiology & Immunology (topic-inferred)$455Kaward amount
- 5R01AI165426-02R01Contact PIAntibiotic tolerance: membraneless organelles and autolysin regulationSt. Jude Children's Research Hospital · Microbiology & Immunology (topic-inferred)$455Kaward amount
Award organization
Organizations that administered FY2023 awards listing Tuomanen, Elaine I as a PI.
FY2023 award administered by St. Jude Children's Research Hospital (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardSt. Jude Children's Research Hospital
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #9718
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2011R01 Grant Holder
- 2018$5M Cumulative Funding